These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 12523876

  • 41. A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder.
    DelBello MP, Adler CM, Whitsel RM, Stanford KE, Strakowski SM.
    J Clin Psychiatry; 2007 May; 68(5):789-95. PubMed ID: 17503991
    [Abstract] [Full Text] [Related]

  • 42. Quetiapine in the successful combination treatment of an assaultive patient with treatment-resistant schizoaffective disorder.
    Post DE.
    Behav Med; 2007 May; 33(1):11-4. PubMed ID: 17517541
    [Abstract] [Full Text] [Related]

  • 43. Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder.
    Rupnow MF, Greenspan A, Gharabawi GM, Kosik-Gonzalez C, Zhu Y, Stahl SM.
    Curr Med Res Opin; 2007 Nov; 23(11):2815-22. PubMed ID: 17910802
    [Abstract] [Full Text] [Related]

  • 44.
    Maglione M, Maher AR, Hu J, Wang Z, Shanman R, Shekelle PG, Roth B, Hilton L, Suttorp MJ, Ewing BA, Motala A, Perry T.
    ; 2011 09. PubMed ID: 22132426
    [Abstract] [Full Text] [Related]

  • 45. A trial of low doses of risperidone in the treatment of patients with first-episode schizophrenia, schizophreniform disorder, or schizoaffective disorder.
    Huq ZU, RIS-GBR-32 Investigators.
    J Clin Psychopharmacol; 2004 Apr; 24(2):220-4. PubMed ID: 15206670
    [Abstract] [Full Text] [Related]

  • 46. Efficacy of atypical antipsychotics in elderly patients with dementia.
    Tariot PN, Profenno LA, Ismail MS.
    J Clin Psychiatry; 2004 Apr; 65 Suppl 11():11-5. PubMed ID: 15264966
    [Abstract] [Full Text] [Related]

  • 47. Cognitive functioning and acute sedative effects of risperidone and quetiapine in patients with stable bipolar I disorder: a randomized, double-blind, crossover study.
    Harvey PD, Hassman H, Mao L, Gharabawi GM, Mahmoud RA, Engelhart LM.
    J Clin Psychiatry; 2007 Aug; 68(8):1186-94. PubMed ID: 17854242
    [Abstract] [Full Text] [Related]

  • 48. Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability.
    Potkin SG, Thyrum PT, Bera R, Carreon D, Alva G, Kalali AH, Yeh C.
    Clin Ther; 2002 Nov; 24(11):1809-23. PubMed ID: 12501876
    [Abstract] [Full Text] [Related]

  • 49. Adjunctive risperidone, olanzapine and quetiapine for the treatment of hospitalized patients with bipolar I disorder: a retrospective study.
    Pae CU, Nassir Ghaemi S, Patkar A, Chae JH, Bahk WM, Jun TY, Masand P.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1322-5. PubMed ID: 16631294
    [Abstract] [Full Text] [Related]

  • 50. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.
    Torrent C, Martinez-Arán A, Daban C, Amann B, Balanzá-Martínez V, del Mar Bonnín C, Cruz N, Franco C, Tabarés-Seisdedos R, Vieta E.
    Compr Psychiatry; 2011 Sep 30; 52(6):613-22. PubMed ID: 21295774
    [Abstract] [Full Text] [Related]

  • 51. Low-dose risperidone and quetiapine as monotherapy for comorbid anxiety and depression.
    Galynker I, Khan A, Grebchenko Y, Ten A, Malaya L, Yanowitch P, Cohen LJ.
    J Clin Psychiatry; 2005 Apr 30; 66(4):544. PubMed ID: 15816805
    [No Abstract] [Full Text] [Related]

  • 52. [Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
    Danileviciūte V.
    Medicina (Kaunas); 2002 Apr 30; 38(11):1057-65. PubMed ID: 12532717
    [Abstract] [Full Text] [Related]

  • 53. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP, Katz IR, Brodaty H, Lyons B, Greenspan A, Burns A.
    Clin Neurol Neurosurg; 2005 Oct 30; 107(6):497-508. PubMed ID: 15922506
    [Abstract] [Full Text] [Related]

  • 54. Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine.
    Kinon BJ, Basson BR, Gilmore JA, Malcolm S, Stauffer VL.
    J Clin Psychiatry; 2000 Nov 30; 61(11):833-40. PubMed ID: 11105736
    [Abstract] [Full Text] [Related]

  • 55. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
    Katzman MA, Vermani M, Jacobs L, Marcus M, Kong B, Lessard S, Galarraga W, Struzik L, Gendron A.
    J Anxiety Disord; 2008 Dec 30; 22(8):1480-6. PubMed ID: 18455360
    [Abstract] [Full Text] [Related]

  • 56. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L, Flegar SJ, Wang J, Rummel-Kluge C, Komossa K, Leucht S.
    Cochrane Database Syst Rev; 2013 Nov 18; (11):CD006625. PubMed ID: 24249315
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
    Calabrese JR, Keck PE, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson E, Mullen J.
    Am J Psychiatry; 2005 Jul 18; 162(7):1351-60. PubMed ID: 15994719
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.